86301004: Posterior pituitary hormone (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Substance with molecular messenger mechanism of action (substance)\Hormone\Pituitary hormone\Posterior pituitary hormone

\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Hormone\Pituitary hormone\Posterior pituitary hormone

Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2018. Module: SNOMED CT core

Descriptions:

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Posterior pituitary hormone	Is a	Hypothalamic or pituitary hormone	false	Inferred relationship	Some
Posterior pituitary hormone	Is a	Pituitary hormone	true	Inferred relationship	Some
Posterior pituitary hormone	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Posterior pituitary hormone (disposition)	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Product containing oxytocin (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Posterior pituitary hormone	Inferred relationship	Some
produit contenant de la lypressine	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Posterior pituitary hormone	Inferred relationship	Some
Oxytocic preparation	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Posterior pituitary hormone	Inferred relationship	Some
Desmopressin acetate 10 microgram/actuation nasal spray	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Posterior pituitary hormone	Inferred relationship	Some
Desmopressin acetate 100 microgram oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Posterior pituitary hormone	Inferred relationship	Some
Desmopressin acetate 200 microgram oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Posterior pituitary hormone	Inferred relationship	Some
Desmopressin acetate 100micrograms/1mL intranasal solution	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Posterior pituitary hormone	Inferred relationship	Some
acétate de desmopressine 4 microgrammes/mL, ampoule de 1 mL de solution injectable	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Posterior pituitary hormone	Inferred relationship	Some
Product containing terlipressin (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Posterior pituitary hormone	Inferred relationship	Some
terlipressine 1 mg, fiole de poudre et solvant pour solution injectable	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Posterior pituitary hormone	Inferred relationship	Some
vasopressine 20 UI/mL, ampoule de 1 mL pour injection	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Posterior pituitary hormone	Inferred relationship	Some
Product containing precisely ergometrine maleate 500 microgram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Posterior pituitary hormone	Inferred relationship	Some
maléate d'ergonovine 500 microgrammes/1mL pour injection	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Posterior pituitary hormone	Inferred relationship	Some
maléate d'ergométrine et oxytocine 500 microgrammes/5 unités/mL, ampoule de 1 mL de solution injectable	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Posterior pituitary hormone	Inferred relationship	Some
Oxytocin 5units/mL injection solution 1mL ampule	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Posterior pituitary hormone	Inferred relationship	Some
Oxytocin 10units/mL injection solution 1mL ampule	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Posterior pituitary hormone	Inferred relationship	Some
Product containing ergometrine and oxytocin (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Posterior pituitary hormone	Inferred relationship	Some
Antidiuretic hormone product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Posterior pituitary hormone	Inferred relationship	Some
Ergonovine maleate 200mcg/mL injection solution ampule	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Posterior pituitary hormone	Inferred relationship	Some
Desmopressin acetate 1.5mg/mL spray	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Posterior pituitary hormone	Inferred relationship	Some
Methylergonovine maleate 0.2mg/mL injection	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Posterior pituitary hormone	Inferred relationship	Some
Desmopressin acetate 0.01% solution	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Posterior pituitary hormone	Inferred relationship	Some
Oxytocin 10unt infusion solution 1mL vial	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Posterior pituitary hormone	Inferred relationship	Some
Vasopressin 20unt/mL injection	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Posterior pituitary hormone	Inferred relationship	Some
Desmopressin acetate 0.1mg tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Posterior pituitary hormone	Inferred relationship	Some
Desmopressin acetate 0.2mg tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Posterior pituitary hormone	Inferred relationship	Some
Desmopressin acetate 0.1mg/mL solution	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Posterior pituitary hormone	Inferred relationship	Some
Desmopressin acetate 0.01% spray	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Posterior pituitary hormone	Inferred relationship	Some
Methylergonovine maleate 0.2mg/cc	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Posterior pituitary hormone	Inferred relationship	Some
Product containing precisely methylergometrine maleate 20 microgram/1 each conventional release oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Posterior pituitary hormone	Inferred relationship	Some
Urea 40-50% injection solution vial	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Posterior pituitary hormone	Inferred relationship	Some
Product containing posterior pituitary hormone (product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Posterior pituitary hormone	Inferred relationship	Some	1
Product containing methylergometrine (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Posterior pituitary hormone	Inferred relationship	Some
Product containing desmopressin acetate	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Posterior pituitary hormone	Inferred relationship	Some
Product containing methylergometrine maleate	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Posterior pituitary hormone	Inferred relationship	Some
Product containing vasopressin tannate	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Posterior pituitary hormone	Inferred relationship	Some
Product containing ergometrine (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Posterior pituitary hormone	Inferred relationship	Some
Product containing vasopressin	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Posterior pituitary hormone	Inferred relationship	Some
Product containing desmopressin (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Posterior pituitary hormone	Inferred relationship	Some
Lypressin preparation	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Posterior pituitary hormone	Inferred relationship	Some
Ergonovine maleate preparation	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Posterior pituitary hormone	Inferred relationship	Some
Vasopressin 20unt/mL injection solution 10mL vial	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Posterior pituitary hormone	Inferred relationship	Some
Vasopressin 20unt/mL injection solution 0.5mL vial	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Posterior pituitary hormone	Inferred relationship	Some
Vasopressin 20unt/mL injection solution 1mL vial	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Posterior pituitary hormone	Inferred relationship	Some
Product containing ergometrine maleate	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Posterior pituitary hormone	Inferred relationship	Some
Dinoprostone 10mg suppository	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Posterior pituitary hormone	Inferred relationship	Some
Dinoprostone 500 microgram oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Posterior pituitary hormone	Inferred relationship	Some
dinoprostone 1 mg/mL, ampoule de 0,75 mL de concentré pour perfusion	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Posterior pituitary hormone	Inferred relationship	Some
dinoprostone 10 mg/mL, ampoule de 0,5 mL de concentré pour perfusion	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Posterior pituitary hormone	Inferred relationship	Some
dinoprostone 10 mg/mL, ampoule de 0,5 mL de concentré avec diluant pour injection	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Posterior pituitary hormone	Inferred relationship	Some
Dinoprostone 400 microgram/mL vaginal gel	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Posterior pituitary hormone	Inferred relationship	Some
Product containing precisely dinoprostone 800 microgram/1 milliliter conventional release vaginal gel (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Posterior pituitary hormone	Inferred relationship	Some
Dinoprostone 3 mg vaginal tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Posterior pituitary hormone	Inferred relationship	Some
Mifepristone 200 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Posterior pituitary hormone	Inferred relationship	Some
Product containing dinoprostone in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Posterior pituitary hormone	Inferred relationship	Some
Product containing dinoprostone in parenteral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Posterior pituitary hormone	Inferred relationship	Some
Dinoprostone-containing product in vaginal dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Posterior pituitary hormone	Inferred relationship	Some
Product containing dinoprostone (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Posterior pituitary hormone	Inferred relationship	Some
Product containing mifepristone (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Posterior pituitary hormone	Inferred relationship	Some
Dinoprostone 10mg insert	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Posterior pituitary hormone	Inferred relationship	Some
Oxytocin	Is a	True	Posterior pituitary hormone	Inferred relationship	Some
Antidiuretic hormone	Is a	True	Posterior pituitary hormone	Inferred relationship	Some
Adverse reaction to posterior pituitary hormones	Causative agent (attribute)	True	Posterior pituitary hormone	Inferred relationship	Some	1
Adverse reaction to posterior pituitary hormone NOS	Causative agent (attribute)	False	Posterior pituitary hormone	Inferred relationship	Some
Posterior pituitary hormone poisoning NOS	Causative agent (attribute)	False	Posterior pituitary hormone	Inferred relationship	Some
Poisoning by posterior pituitary hormone	Causative agent (attribute)	True	Posterior pituitary hormone	Inferred relationship	Some	1
Lypressin adverse reaction	Causative agent (attribute)	False	Posterior pituitary hormone	Inferred relationship	Some
Accidental vasopressin poisoning	Causative agent (attribute)	False	Posterior pituitary hormone	Inferred relationship	Some
Adverse reaction caused by antidiuretic hormone	Causative agent (attribute)	False	Posterior pituitary hormone	Inferred relationship	Some
Desmopressin adverse reaction	Causative agent (attribute)	False	Posterior pituitary hormone	Inferred relationship	Some
Terlipressin adverse reaction	Causative agent (attribute)	False	Posterior pituitary hormone	Inferred relationship	Some
Poisoning by vasopressin	Causative agent (attribute)	False	Posterior pituitary hormone	Inferred relationship	Some
Intentional vasopressin poisoning	Causative agent (attribute)	False	Posterior pituitary hormone	Inferred relationship	Some
Vasopressin poisoning of undetermined intent	Causative agent (attribute)	False	Posterior pituitary hormone	Inferred relationship	Some
Terlipressin acetate (substance)	Is a	True	Posterior pituitary hormone	Inferred relationship	Some
Lypressin (substance)	Is a	True	Posterior pituitary hormone	Inferred relationship	Some
Argipressin (substance)	Is a	True	Posterior pituitary hormone	Inferred relationship	Some
Vasopressin tannate (substance)	Is a	True	Posterior pituitary hormone	Inferred relationship	Some
Terlipressin (substance)	Is a	True	Posterior pituitary hormone	Inferred relationship	Some

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
143127018	Posterior pituitary hormone	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
828537018	Posterior pituitary hormone (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
7120291000241115	hormone de l'hypophyse postérieure	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
7120301000241116	hormone posthypophysaire	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
7120311000241119	hormone neurohypophysaire	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module